These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 23062049

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Double trouble-pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research.
    Clark N, Verster A.
    Addiction; 2013 Feb; 108(2):253-5. PubMed ID: 23331880
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.
    Soyka M, Kranzler HR, van den Brink W, Krystal J, Möller HJ, Kasper S, WFSBP Task Force on Treatment, Guidelines for Substance Use Disorders.
    World J Biol Psychiatry; 2011 Apr; 12(3):160-87. PubMed ID: 21486104
    [Abstract] [Full Text] [Related]

  • 5. Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
    Gerra G, Zaimovic A, Rustichelli P, Fontanesi B, Zambelli U, Timpano M, Bocchi C, Delsignore R.
    J Subst Abuse Treat; 2000 Mar; 18(2):185-91. PubMed ID: 10716102
    [Abstract] [Full Text] [Related]

  • 6. A 'miracle cure' misunderstood.
    Brewer C.
    Addiction; 2012 Aug; 107(8):1528. PubMed ID: 22594709
    [No Abstract] [Full Text] [Related]

  • 7. Unexpected delirium during Rapid Opioid Detoxification (ROD).
    Golden SA, Sakhrani DL.
    J Addict Dis; 2004 Aug; 23(1):65-75. PubMed ID: 15077841
    [Abstract] [Full Text] [Related]

  • 8. Transfer from high dose methadone to buprenorphine/naloxone.
    Wallace M.
    Aust Nurs J; 2011 Jul; 19(1):42-3. PubMed ID: 21853690
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Double successful buprenorphine/naloxone induction to facilitate cardiac transplantation in an iatrogenically opiate-dependent patient.
    Rodgman C, Pletsch G.
    J Addict Med; 2012 Jun; 6(2):177-8. PubMed ID: 22456493
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The pharmacological treatment of opioid addiction--a clinical perspective.
    Lobmaier P, Gossop M, Waal H, Bramness J.
    Eur J Clin Pharmacol; 2010 Jun; 66(6):537-45. PubMed ID: 20169438
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Management of opioid withdrawal symptoms.
    Med Lett Drugs Ther; 2018 Aug 27; 60(1554):137-141. PubMed ID: 30133420
    [No Abstract] [Full Text] [Related]

  • 16. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.
    Sigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G.
    Am J Drug Alcohol Abuse; 2012 May 27; 38(3):187-99. PubMed ID: 22404717
    [Abstract] [Full Text] [Related]

  • 17. [Evolution and update of detoxification techniques for opiate addicts].
    Yui K.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct 27; 20(4):175-7. PubMed ID: 11215403
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Commercial factors override science in combination addiction drug trial.
    Byrne A.
    Clin Pharmacol Ther; 2011 Nov 27; 90(5):649; author reply 650. PubMed ID: 21956617
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.